Business & Tech
Emergent BioSolutions Strikes $222 Million Deal to Buy Canadian Firm
Washington Post: Montgomery County-based bio-defense contractor is trying to expand footprint with foray into commercial market.
Montgomery County-based firm Emergent BioSolutions struck a $222 million deal to buy a Canadian firm, Cangene Corp., The Baltimore Sun reports.
The deal is subject to a two-thirds vote by Cangene shareholders and approval by a Canadian, The Baltimore Sun reports.
Emergent is the only FDA-licensed maker the anthrax vaccine. The vaccine is manufactured at a facility in Michigan, but the company’s headquarters is in Montgomery County. Patch reported in September that Emergent is planning to relocate from Rockville to Gaithersburg.
Interested in local real estate?Subscribe to Patch's new newsletter to be the first to know about open houses, new listings and more.
The deal was the Emergent’s attempt to expand from its roots as a federal contractor, The Washington Post reports.
Cangene is best known for its drug WinRho, which treats a blood disorder in newborns, The Post reports.
Interested in local real estate?Subscribe to Patch's new newsletter to be the first to know about open houses, new listings and more.
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.
We’ve removed the ability to reply as we work to make improvements. Learn more here
